MMP-2 is involved in synaptic remodeling after cochlear lesion

NeuroReport

Volumn 21, Issue 5, 2010, Pages 324-327

  Fredrich, Michaela ^a   Illing, Robert Benjamin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cochlear nucleus; Cochleotomy; Matrix metalloprotease 2; Rat; Regeneration; Synaptogenesis

Indexed keywords

GELATINASE A; NEUROMODULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; COCHLEAR NUCLEUS; CONTROLLED STUDY; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; INNER EAR DISEASE; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPSE; SYNAPTOGENESIS;

ANIMALS; ASTROCYTES; AXONS; COCHLEA; FLUORESCENT ANTIBODY TECHNIQUE; GAP-43 PROTEIN; MATRIX METALLOPROTEINASE 2; NEURONAL PLASTICITY; NEURONS; RATS; RATS, WISTAR; SYNAPSES; TIME FACTORS;

EID: 77949441527     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328335b518     Document Type: Article

References (25)

1. Kane EC. Patterns of degeneration in the caudal cochlear nucleus of the cat after cochlear ablation. Anat Rec 1974; 179:67-91.
2. Costanzo RM, Perrino LA. Peak in matrix metalloproteinases-2 levels observed during recovery from olfactory nerve injury. Neuroreport 2008; 19:327-331.
3. Ahmed Z, Dent RG, Leadbeater WE, Smith C, Berry M, Logan A. Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Mol Cell Neurosci 2005; 28:64-78.
4. Kawasaki Y, Xu ZZ,Wang X, Park JY, Zhuang ZY, Tan PH, et al. Distinct roles of matrix metalloproteases in the early-and late-phase development of neuropathic pain. Nat Med 2008; 14:331-336.
5. Hsu JYC, McKeon R, Goussev S, Werb Z, Lee JU, Trivedi A, et al. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci 2006; 26:9841-9850.
6. Ranasinghe HS, Williams CE, Christophidis LJ, Mitchell MD, Fraser M, Scheepens A. Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury. Neuroscience 2009; 158:732-744.
7. Tsukatani T, Fillmore HL, Hamilton HR, Holbrook EH, Costanzo RM. Matrix metalloproteinase expression in the olfactory epithelium. Neuroreport 2003; 14:1135-1140.
8. Ethell IM, Ethell DW. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 2007; 85:2813-2823.
9. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S. Unaltered secretion of b-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 1997; 272:22389-22392.
10. Illing RB, Horvá th M, Laszig R. Plasticity of the auditory brainstem: effects of cochlear ablation on GAP-43 immunoreactivity in the rat. J Comp Neurol 1997; 382:116-138.
11. Meidinger MA, Hildebrandt-Schoenfeld H, Illing R-B. Cochlear damage induces GAP-43 expression in cholinergic synapses of the cochlear nucleus in the adult rat: a light and electron microscopic study. Europ J Neurosci 2006; 23:3187-3199.
12. Kraus KS, Illing RB. Superior olivary contributions to auditory system plasticity: medial but not lateral olivocochlear neurons are the source of cochleotomy-induced GAP-43 expression in the ventral cochlear nucleus. J Comp Neurol 2004; 475:374-390.
13. Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999; 22:208-215.
14. Theodosis DT, Poulain DA, Oliet SHR. Activity-dependent structural and functional plasticity of astrocyte-neuron interactions. Physiol Rev 2008; 88:983-1008.
15. Allen NJ, Barres BA. Signaling between glia and neurons: focus on synaptic plasticity. Curr Opin Neurobiol 2005; 15:542-548.
16. Pfrieger FW, Barres BA. Synaptic efficacy enhanced by glial cells in vitro. Science 1997; 277:1684-1687.
17. Campos-Torres A, Touret M, Vidal PP, Barnum S, deWaele C. The differential response of astrocytes within the vestibular and cochlear nuclei following unilateral labyrinthectomy or vestibular afferent activity blockade by transtympanic tetrodotoxin injection in the rat. Neuroscience 2005; 130:853-865.
18. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, et al. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Mol Brain Res 2002; 100:103-117.
19. Goussev S, Hsu JYC, Lin Y, Tjoa T, Maida N, Werb Z, et al. Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing. J Neurosurg 2003; 99:188-197.
20. Ogier C, Bernard A, Chollet AM, Le Diguardher T, Hanessian S, Charton G, et al. Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia 2006; 54:272-284.
21. Agrawal SM, Lau L, Yong VW. MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 2008; 19:42-51.
22. Dityatev A, Schachner M. Extracellular matrix molecules and synaptic plasticity. Nat Rev Neurosci 2003; 4:456-468.
23. Reeves TM, Prins ML, Zhu JP, Povlishock JT, Phillips LL. Matrix metalloproteinase inhibition alters functional and structural correlates of deafferentation-induced sprouting in dentate gyrus. J Neurosci 2003; 23:10182-10189.
24. Kozlova EN. Strategies to repair lost sensory connections to the spinal cord. Mol Biol (Mosk) 2008; 42:820-829.
25. Rivera S, Khrestchatisky M. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuronal plasticity and pathology. In: Baudry M, Thomson RF, Davis JL, editors. Advances in synaptic plasticity. Cambridge, Massachusetts: The MIT Press; 1999. pp. 53-86.